THE SCHEDULE 13G

Company

Xenon Pharmaceuticals Inc.

Filed

July 10, 2015

Accession Number

0000921895-15-001754

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →